Skip to main content

Table 1 The genome-wide expression profiles of CRC patients used in this study

From: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer

Datasets #GEO Samples
TCGA-COAD GDC 478 cancer and 41 normal samples
TCGA-READ GDC 166 cancer and 10 normal samples
Reumers et al. GSE117606 65 normal, 59 adenoma and 74 tumors
Kim et al. GSE50760 18 normal, 18 tumor and 18 metastasis patients
Sheffer et al. GSE41258 54 normal, 186 tumor, 47 liver and 20 lung metastasis patients
Marra et al. GSE8671 32 normal and 32 tumors
Uddin et al. GSE23878 24 normal and 35 tumors
Skrzypczak et al. GSE20916 34 normal, 45 adenoma and 36 adenocarcinoma
Matsuyama et al. GSE18105 17 normal, 17 tumor and 77 laser-capture microdissection patients
Smith et al. GSE17536 177 patient with overall survival and disease-free survival
Jorissen et al. GSE14333 226 patients with survival time